Article
Gut delivery of pentameric GLP-1 using genetically engineered <i>Bacillus subtilis</i>
2025-10-07
Abstract excerpt
Glucagon-like peptide-1 (GLP-1) receptor agonists and GLP-1 analogs are widely used for type 2 diabetes and weight management, but current approaches can be limited by manufacturing complexity, cost, formulation requirements, and the need for repeated administration. Living microbial delivery systems offer a potential strategy for sustained gastrointestinal production of therapeutic peptides, yet achieving stable...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 61223ad7-7776-5931-9411-99595ea25ae7
- DOI
- 10.1101/2025.10.07.680898
